Rebecca Taub, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 1,000 shares at $350.01 ($350K) on 2025-07-18, disclosed to the SEC on 2025-07-22.
Scheduled sale ($350k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MDGL | SELL | 2026-01-20 | $1.1M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $18.9M | — | Filing → |
| MDGL | SELL | 2026-01-13 | $242K | — | Filing → |